Tryptophanol

Tryptophanol

SCHEMBL5154588

N[C@@H](CO)Cc1c[nH]c2ccccc12.O=C(N[C@@H](CO)Cc1c[nH]c2ccccc12)c1cc(-c2ccc(OC(F)(F)F)cc2)nc2ccccc12.O=C(O)c1cc(-c2ccc(OC(F)(F)F)cc2)nc2ccccc12

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.44
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 1/20 0.43
PTBP1 P26599 1/20 0.43
HTT P42858 1/20 0.43
TRPV1 Q8NER1 2/20 0.43
DHODH Q02127 2/20 0.43
SCN9A Q15858 2/20 0.42
TACR3 P29371 5/20 0.42
TP53 P04637 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
RUVBL1 Q9Y265 1/20 0.41
AKT1 P31749 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602177 0.93 TRPV1 (0.49) CDK2LMNASMN1; SMN2MAPTPTBP1
Tryptophanol SCHEMBL5155681 0.86 TACR3 (0.45) LMNASMN1; SMN2MAPTDHODHTACR3
Tryptophanol SCHEMBL5155750 0.86 MEN1 (0.48) LMNASMN1; SMN2MAPTHTTDHODH
SCHEMBL5154442 0.85 TACR3 (0.57) LMNASMN1; SMN2MAPTHTTTACR3
SCHEMBL14557585 0.81 ITGB2 (0.42) CDK2LMNASMN1; SMN2MAPTPTBP1
SCHEMBL4601284 0.81 TACR3 (0.53) LMNASMN1; SMN2MAPTHTTTACR3
SCHEMBL14557563 0.81 KDM4E (0.56) LMNASMN1; SMN2MAPTTACR3TP53
SCHEMBL4601942 0.79 ITGB2 (0.50) LMNASMN1; SMN2MAPTTACR3TP53
SCHEMBL4600729 0.79 TACR3 (0.49) MAPTTACR3ALDH1A1HPGD
SCHEMBL4602563 0.79 KDM4E (0.57) LMNASMN1; SMN2MAPTHTTDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R CDK2 1146/4885LMNA 3198/4885SMN1; SMN2 3867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.